Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPT with MQ+AS or SP+AQ for Malaria Prevention in Sickle Cell Anaemia
NCT01319448Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2011
- Primary completion
- Apr 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mefloquine, artesunate, sulfadoxine, pyrimethamine, amodiaquine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Sep 2011; status: completed.
02
Drugs
mefloquineartesunatesulfadoxinepyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01319448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01319448.